Non-myeloablative Conditioning
1 clinical trials · Condition
◉ Watch Non-myeloablative Conditioning
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant (NCT01930162) | Novartis Pharmaceuticals | 2014-10-07 |
Track Non-myeloablative Conditioning automatically
Every clearance here is in the API, with alerts when new ones post.